Patents by Inventor Brendon Conlan

Brendon Conlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070215475
    Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.
    Type: Application
    Filed: December 4, 2006
    Publication date: September 20, 2007
    Inventors: Elizabeth Seabrook, Thomas Turton, Brendon Conlan
  • Patent number: 7144487
    Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: December 5, 2006
    Assignee: Life Therapeutics, Inc.
    Inventors: Elizabeth Jean Seabrook, Thomas Norman Turton, Brendon Conlan
  • Patent number: 7077942
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: July 18, 2006
    Assignee: Gradipore Limited
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Patent number: 7060173
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: June 13, 2006
    Assignee: Gradipore Limited
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Publication number: 20050224355
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Application
    Filed: December 7, 2001
    Publication date: October 13, 2005
    Inventors: Brendon Conlan, Tracey Edgell, May Lazar, Chenicheri Nair, Elizabeth Seabrook, Thomas Turton
  • Publication number: 20030106798
    Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.
    Type: Application
    Filed: July 15, 2002
    Publication date: June 12, 2003
    Applicant: Gradipore Limited
    Inventors: Elizabeth Jean Seabrook, Thomas Norman Turton, Brendon Conlan
  • Publication number: 20030019763
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Application
    Filed: January 2, 2002
    Publication date: January 30, 2003
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Patent number: 6464851
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: October 15, 2002
    Assignee: Gradipore Limited
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Publication number: 20020084187
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Application
    Filed: June 22, 2001
    Publication date: July 4, 2002
    Applicant: Gradipore Limited
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Haribaran Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Patent number: 6402913
    Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/&agr;-1-antitrypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and &agr;-1-antitrypsin from the albumin/&agr;-1-antitrypsin pool.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: June 11, 2002
    Assignee: Gradipore Limited
    Inventors: Andrew Mark Gilbert, Brendon Conlan, Chenicheri Hariharan Nair
  • Publication number: 20020000386
    Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st
    Type: Application
    Filed: August 16, 2001
    Publication date: January 3, 2002
    Applicant: Gradipore Ltd.
    Inventors: Brendon Conlan, Tracey Ann Edgell, May Lazar, Chenicheri Hariharan Nair, Elizabeth Jean Seabrook, Thomas Norman Turton
  • Patent number: RE39293
    Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/?-1-antirypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and ?-1-antitrypsin from the albumin/?-1-antitrypsin pool.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: September 19, 2006
    Assignee: Life Therapeutics Limited
    Inventors: Andrew Mark Gilbert, Brendon Conlan, Chenicheri Hariharam Nair